”Potential of Dried Blood Self-Sampling for Cyclosporine C2 Monitoring in Transplant Outpatients”;
A.B. Leichtle, U. Ceglarek, H. Witzigmann, G. Gäbel, J. Thiery and G. M. Fiedle; J Transplant. 2010; 2010: 201918.
Newsroom
- Capitainer’s qDBS dried blood spot system for home self-sampling proves 97% effective for clinical mass-testing of Covid-19 vaccine efficacy
- Capitainer attracts former Karolinska University Hospital Laboratory Unit Manager Mikael Ström as Business Development Manager
- Sweden’s Västerbotten Region first to introduce home sampling for COVID-19 antibodies together with Capitainer
- New study shows that the new Capitainer PEth system tailored for analysis of PEth enables accurate and court-admissible monitoring of alcohol abuse
- Capitainer’s qDBS dried blood spot system for home sample collection employed in a nation-wide COVID-19 study in the US
- Capitainer raises further SEK31 million to meet anticipated demand for qDBS dried blood spot sampling system as COVID-19 vaccine programs are rolled out
- Capitainer awarded ISO 13485:2016 as interest grows in qDBS testing for COVID-19 and other challenging applications
